| (210) | Number of the EPO application | 16785611 |
| (220) | Filing date of the EPO application | 2016.10.05 |
| (80) | EPO patent specification publication (B) | EPB nr. 02/2022, 2022.01.12 |
| (110) | EPO patent number | 3359528 |
| (21) | Number of the application | e 2018 0795 |
| (71) | Name(s) of applicant(s), code of the country | MITOBRIDGE, INC., US;
The Salk Institute for Biological Studies, US; |
| (72) | Name(s) of inventor(s), code of the country | DOWNES Michael, US;
EVANS Ronald M., US;
KLUGE Arthur, US;
LAGU Bharat, US;
MIURA Masanori, JP;
PANIGRAHI Sunil Kumar, IN;
PATANE Michael, US;
SAMAJDAR Susanta, IN;
SENAIAR Ramesh, IN;
TAKAHASHI Taisuke, JP; |
| (73) | Name(s) of owner(s), code of the country | MITOBRIDGE INC., US;
The Salk Institute for Biological Studies, US; |
| (54) | Title of the invention | PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 233/64 (2006.01.01); C07D 401/04 (2006.01.01); C07D 405/10 (2006.01.01); A61K 31/4174 (2006.01.01); A61K 31/4439 (2006.01.01); A61P 21/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.09.30 |
| (30) | Priority | 201562238629 P, 2015.10.07, US; 201562243263 P, 2015.10.19, US; 201662352348 P, 2016.06.20, US |
| (86) | International application | PCT/US2016/055521, 2016.10.05 |
| (87) | International publication | WO 2017/062468, 2017.04.13 |